Tilray Brands, Inc.
TLRY Nasdaq Medicinal Chemicals & Botanical Products 金融 FY2017–FY2026
最新收盘价 · 2026年10月23日
$2.81
4.1%Tilray Brands, Inc. 的业务
暂无业务介绍。
- 法定名称
- Tilray Brands, Inc.
- 财年结束日
- 2026年5月31日
- 最新年报
- 10-K · 2026年7月28日
- 登记号 · CIK
- 0001437749-26-024698
0001731348
营收与利润率
Tilray Brands, Inc. 在 2026 财年 营收为 $915M,同比增长 11.5%。
净利润与每股收益
亏损期间以红色显示。
资本回报率
税后营业利润占投入业务资金(债务加股东权益减现金)的比例。
现金流
2026 财年 的自由现金流为 —,占营收的 —。 经营现金流减资本支出。
股息、回购与股数
Tilray Brands, Inc. 在 2026 财年 向股东返还 —。 稀释股数增加 25.6%。
资产负债表
现金、债务以及显示 Tilray Brands, Inc. 承担债务能力的指标。
| 财年末 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| 现金及短期投资 | $416M | $449M | $261M | $256M | $231M |
| 债务(含融资租赁) | $204M | $23.4M | $63.1M | $53.0M | $254M |
| 债务 / 股东权益 | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x |
| 利息保障倍数 | −15.4x | −29.4x | −3.5x | −55.2x | −2.1x |
| 流动比率 | 2.9x | 1.8x | 2.3x | 2.5x | 2.2x |
| 速动比率 | 2.0x | 1.3x | 1.4x | 1.5x | 1.4x |
| 总资产 | $5.4B | $4.3B | $4.2B | $2.1B | $2.3B |
| 总负债 | $1.0B | $977M | $778M | $585M | $733M |
| 股东权益 | $4.4B | $3.3B | $3.4B | $1.5B | $1.6B |
| 净债务 (− = 净现金) | −$212M | −$425M | −$197M | −$203M | $22.7M |
内部人交易
高管、董事和持股超过 10% 的股东在公开市场的买卖,数据来自 Form 4 申报。“计划”表示依据事先制定的 Rule 10b5-1 计划进行的交易。
买入(12 个月)
$0.0M
0 名内部人士
卖出(12 个月)
$0.0M
0 名内部人士
卖出中按计划执行的比例
—
$0.0M
过去 12 个月没有公开市场的内部人交易。
Piotroski F 分数
关于盈利能力、融资和效率的九项通过/未通过测试。8–9 为强,0–2 为弱。
| 测试项 | FY17 | FY18 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| 净利润为正 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| 经营现金流为正 | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ |
| 资产回报率上升 | — | — | — | ✕ | ✕ | ✓ | ✕ | ✓ |
| 经营现金流高于净利润 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 债务相对资产下降 | — | — | — | ✕ | ✓ | ✓ | ✓ | ✕ |
| 流动比率上升 | — | — | — | ✓ | ✕ | ✓ | ✓ | ✕ |
| 股数未增加 | — | ✓ | — | ✕ | ✕ | ✓ | ✕ | ✕ |
| 毛利率上升 | — | ✓ | — | ✕ | ✓ | ✓ | ✓ | ✕ |
| 营收相对资产上升 | — | — | — | ✓ | ✓ | ✓ | ✓ | ✕ |
| F 分数 | — / 3 | — / 5 | — / 3 | 3 / 9 | 5 / 9 | 7 / 9 | 5 / 9 | 2 / 9 |
| 应计比率 | — | −3.3% | −0.4% | −5.2% | −29.9% | −5.0% | −66.5% | −2.4% |
| Altman Z'' | — | −8.06 | 3.20 | 3.88 | 0.12 | 2.90 | −11.01 | −3.61 |
8 年数据
金额单位为 USD。将鼠标悬停在指标名称上可查看定义。
| 财年 | FY17 | FY18 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| 利润表 | ||||||||
| 营收 | $12.6M | $20.5M | $43.1M | $628M | $627M | $789M | $821M | $915M |
| 毛利 | $2.7M | $11.4M | $14.3M | $117M | $147M | $223M | $241M | $260M |
| 研发支出 | $1.1M | $3.2M | $5.9M | $1.5M | $0.7M | $0.6M | $0.3M | $0.4M |
| 营业利润 | −$7.0M | −$7.5M | −$57.8M | −$610M | −$1.4B | −$175M | −$2.3B | −$63.0M |
| 利息支出 | $0.8M | $0.7M | $5.7M | $39.7M | $46.6M | $49.3M | $41.3M | $29.9M |
| 税前利润 | −$7.9M | −$7.8M | −$72.2M | −$441M | −$1.5B | −$249M | −$2.3B | −$88.1M |
| 所得税 | — | — | −$4.5M | −$6.5M | −$7.2M | −$26.6M | −$121M | $17.1M |
| 净利润 | −$7.9M | −$7.8M | −$67.7M | −$477M | −$1.5B | −$245M | −$2.2B | −$121M |
| 稀释每股收益 | −$0.11 | −$0.10 | −$0.82 | −$0.99 | −$2.35 | −$3.30 | −$24.56 | −$1.09 |
| 稀释股数 | 0.08B | 0.08B | 0.08B | 0.48B | 0.62B | 0.07B | 0.09B | 0.11B |
| 现金流 | ||||||||
| 经营现金流 | −$3.3M | −$6.0M | −$46.2M | −$177M | $7.9M | −$30.9M | −$94.6M | −$69.1M |
| 资本支出 | $0.5M | $10.9M | $50.2M | $34.1M | $20.8M | $29.2M | $32.9M | — |
| 自由现金流 | −$3.8M | −$16.9M | −$96.4M | −$211M | −$12.9M | −$60.2M | −$128M | — |
| 折旧与摊销 | $2.0M | $1.9M | $3.6M | $155M | — | — | — | — |
| 股权激励 | $0.1M | $0.1M | $21.0M | $36.0M | $39.6M | $31.8M | $24.3M | $45.9M |
| 收购 | — | — | — | −$0.3M | $26.7M | $60.6M | $18.1M | $53.7M |
| 资产负债表 | ||||||||
| 现金及短期投资 | $7.5M | $2.3M | $488M | $416M | $449M | $261M | $256M | $231M |
| 总债务 | — | $9.4M | $213M | $204M | $23.4M | $18.0M | $7.2M | $129M |
| 融资租赁负债 | — | — | — | — | — | $45.0M | $45.9M | $125M |
| 流动资产 | — | $12.4M | $884M | $804M | $773M | $678M | $689M | $792M |
| 流动负债 | — | $50.2M | $401M | $280M | $433M | $299M | $280M | $358M |
| 存货 | — | $7.4M | $256M | $246M | $201M | $252M | $271M | $301M |
| 固定资产净额 | — | $40.0M | $651M | $587M | $430M | $558M | $568M | $680M |
| 商誉 | — | — | $2.8B | $2.6B | $2.0B | $2.0B | $752M | $752M |
| 无形资产 | — | $0.9M | $1.6B | $1.3B | $974M | $915M | $21.4M | $42.8M |
| 总资产 | — | $53.9M | $6.0B | $5.4B | $4.3B | $4.2B | $2.1B | $2.3B |
| 总负债 | — | $58.8M | $1.6B | $1.0B | $977M | $778M | $585M | $733M |
| 优先股 | — | — | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| 股东权益 | $2.5M | −$4.9M | $4.5B | $4.4B | $3.3B | $3.4B | $1.5B | $1.6B |
| 利润率 | ||||||||
| 毛利率 | 21.1% | 55.4% | 33.1% | 18.6% | 23.4% | 28.3% | 29.3% | 28.4% |
| 营业利润率 | −55.7% | −36.5% | −134.1% | −97.1% | −218.4% | −22.1% | −277.9% | −6.9% |
| EBITDA 利润率 | −40.3% | −27.5% | −125.8% | −72.5% | — | — | — | — |
| 净利率 | −62.3% | −38.0% | −157.0% | −75.9% | −231.6% | −31.1% | −266.3% | −13.3% |
| 自由现金流利润率 | −30.1% | −82.3% | −223.6% | −33.6% | −2.1% | −7.6% | −15.5% | — |
| 回报率 | ||||||||
| 资本回报率 | — | −262.4% | −1.1% | −11.5% | −37.4% | −4.3% | −142.9% | −3.3% |
| 已动用资本回报率 | — | −201.2% | −1.0% | −11.8% | −35.4% | −4.5% | −127.2% | −3.2% |
| 股本回报率 | −311.8% | — | −1.5% | −10.8% | −37.7% | −7.2% | −88.3% | −7.8% |
| 资产回报率 | — | −14.5% | −1.1% | −8.3% | −29.8% | −5.7% | −69.5% | −5.5% |
| 有形股本回报率 | −311.8% | — | −332.7% | −99.4% | −436.1% | −47.2% | −296.4% | −14.8% |
| 增长 | ||||||||
| 营收增长 | — | 62.4% | — | 1,356.9% | −0.2% | 25.8% | 4.1% | 11.5% |
| 股数变化 | — | 0.0% | — | 479.7% | 28.4% | −88.0% | 19.9% | 25.6% |
| 财务健康 | ||||||||
| 债务 / 股东权益 | — | — | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x |
| 利息保障倍数 | −9.1x | −10.8x | −10.2x | −15.4x | −29.4x | −3.5x | −55.2x | −2.1x |
| 流动比率 | — | 0.2x | 2.2x | 2.9x | 1.8x | 2.3x | 2.5x | 2.2x |
| 速动比率 | — | 0.1x | 1.6x | 2.0x | 1.3x | 1.4x | 1.5x | 1.4x |
| 资本配置 | ||||||||
| 资本支出 / 营收 | 3.9% | 53.1% | 116.4% | 5.4% | 3.3% | 3.7% | 4.0% | — |
| 股权激励 / 营收 | 0.7% | 0.7% | 48.7% | 5.7% | 6.3% | 4.0% | 3.0% | 5.0% |
| 质量评分 | ||||||||
| Piotroski F 分数 | — | — | — | 3.0 | 5.0 | 7.0 | 5.0 | 2.0 |
| Altman Z'' | — | −8.1 | 3.2 | 3.9 | 0.1 | 2.9 | −11.0 | −3.6 |
| 应计比率 | — | −3.3% | −0.4% | −5.2% | −29.9% | −5.0% | −66.5% | −2.4% |
来源:SEC EDGAR XBRL 文件 (CIK 0001731348). 数据更新于 2026年10月24日。 第四季度数据为全年减去前九个月。 仅供参考,不构成投资建议。依赖任何数字前,请核对原始文件。
